Professional Documents
Culture Documents
2016
2013
Moorhouse P, Rockwood K.
J R Coll Physicians Edinb 2012;42:333-340.
2013
2013
which must
be balanced
against the
risk of
hypoglycemi
guidelines.diabetes.ca
| 1-800-BANTING (226-8464)
a
Copyright 2013 Canadian Diabetes Association
| diabetes.ca
2013
Parameter
Target
A1C
8.5%
FPG or
preprandial glucose
5.0-12.0 mmol/L
(depending on level of
frailty)
AVOID HYPOGLYCEMIA
FPG= Fasting Plasma Glucose
Autonomic
symptoms
**
Middle-aged
(39-64 years)
Older
(65 years)
Baseline
Hypo
Recovery
Neuroglycopenic
symptoms
12
*
10
8
6
4
2
0
Baseline
Hypo
Recovery
Bremer JP et al. Diabetes Care. 2009; 32 (8):1513-17
L
I
F
E
S
T
Y
L
E
2016
A1C <8.5%
If not at glycemic
target (2-3 mos)
Start / Increase
metformin
A1C 8.5%
Initiate
insulin +/metformin
CHOICE OF AGENT
Degree of hyperglycemia
Risk of hypoglycemia
Overweight or obesity
Cardiovascular disease or multiple risk factors
Comorbidities (renal, CHF, hepatic)
Preferences & access to treatment
L
I
F
E
S
T
Y
L
E
2016
2016
2013
2013
Recommendation 1
1. Healthy, elderly people with diabetes should be
treated to achieve the same glycemic, blood
pressure, and lipid targets as younger people with
diabetes [Grade D, Consensus].
Recommendation 2
2013
Recommendations 3 and 4
3. In elderly people with cognitive impairment,
strategies should be employed to strictly avoid
hypoglycemia, which include the choice of
antihyperglycemic therapy and less stringent A1C
target [Grade D, Consensus].
4. Elderly people with type 2 diabetes should perform
aerobic exercise and/or resistance training, if not
contraindicated, to improve glycemic control [Grade B,
Level 2].
Recommendation 5
5. In elderly people with T2DM, sulfonylureas should
be used with caution because the risk of
hypoglycemia increases exponentially with age
[Grade D, Level 4].
Recommendation 6
6. In elderly people, thiazolidinediones should be used
with caution due to the increased risk of fractures
and heart failure [Grade D, Consensus].
Recommendations 7 and 8
7. Detemir and glargine may be used instead of NPH
or human 30/70 insulin to lower the frequency of
2013
Recommendations 9 and 10
2013